Abvc Biopharma (ABVC) Revenue (2009 - 2026)
Abvc Biopharma's Revenue was $43,868 in Q2 2026, compared with -$200,108 a year earlier.
Powered by 
Analysis
Abvc Biopharma (ABVC) Revenue (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Abvc Biopharma's Revenue was -$918,445 through Jun 30, 2026; for FY2025, it came in at $31,779, down 93.8% from FY2024.
- Revenue shows a five-year compound annual growth rate of -42.0% (FY2020 to FY2025).
- In earlier years, Revenue was $509,589 in FY2024 (+234.3%), $152,430 in FY2023 (-84.3%), $969,783 in FY2022 (+172.6%) and $355,797 in FY2021 (-26.3%).
- The Q2 2026 figure marks the highest quarterly Revenue since Q3 2024.
- The best year-over-year quarter for Revenue over five years was Q2 2022 (growth of 895.1%); the worst was Q4 2023 (a decline of 99.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 15.07 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 16.58 Bn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43,868.00 |
| Dec 31, 2025 | -764,171.00 |
| Jun 30, 2025 | -200,108.00 |
| Dec 31, 2024 | 1,966.00 |
| Sep 30, 2024 | 389,276.00 |
| Jun 30, 2024 | 117,142.00 |
| Mar 31, 2024 | 1,205.00 |
| Dec 31, 2023 | 2,165.00 |
| Sep 30, 2023 | 15,884.00 |
| Jun 30, 2023 | 6,109.00 |
| Mar 31, 2023 | 128,272.00 |
| Dec 31, 2022 | 588,994.00 |
| Sep 30, 2022 | 42,269.00 |
| Jun 30, 2022 | 312,860.00 |
| Mar 31, 2022 | 25,660.00 |
| Dec 31, 2021 | -37,793.00 |
| Sep 30, 2021 | 98,999.00 |
| Jun 30, 2021 | 31,441.00 |
| Mar 31, 2021 | 263,150.00 |
| Dec 31, 2020 | 62,193.00 |
API Access
Abvc Biopharma Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();